KIDNET vs EMDR vs Waitlist in refugeechildren with PTSD (symptoms) in the Netherlands
- Conditions
- Posttraumatic Stress Disorder (PTSDpartial-)
- Registration Number
- NL-OMON22679
- Lead Sponsor
- Vereniging EMDR Nederland (VEN); EMDR Europe; ZONMW; Stichting tot steun VCVGZ
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 93
Eligible participants for this study must meet all of the following criteria:(1) children and adolescents of ages 8 and 18 years; (2) partial or full PTSD as reported by the child (interviewed with the Clinician-Administered PTSD Scale for DSM 5 - Child/Adolescent Version (CAPS-CA-5; Pynoos et al., 2015)). Partial PTSD is defined as either fulfilling three of the four symptom clusters or one symptom present in each of the four symptom clusters. Participants will be included when they (3) are accompanied by at least one caregiver; (4) applied for asylum in the Netherlands or are residing in the Netherlands since January 2015 or later; (5) elementary reading and writing level.
A potential participant who meets any of the following criteria will be excluded from participation in this study: (1) intelligence level (<80); (2) acute interfering psychiatric disorder that needs to be treated first; (4) brain damage; (5) acute threat of deportation or moving within intervention period; (6) anti-epileptic and neuro epileptic medication; or (7) current severe substance abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Posttraumatic stress symptoms (CAPS-CA, CRIES-13 children and parents)
- Secondary Outcome Measures
Name Time Method Behavioral and emotional symptoms (SDQ)<br>Quality of life (Kidscreen-27)<br>Treatment satisfaction (interview with participant)<br>Anxiety of the caregiver (BAI)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.